United Therapeutics Corporation Stock Forecast
Stronger technical forecast for United Therapeutics Corporation stock price after Thursday trading.
(Updated on Apr 18, 2024)
The United Therapeutics Corporation stock price gained 0.688% on the last trading day (Thursday, 18th Apr 2024), rising from $235.31 to $236.93. During the last trading day the stock fluctuated 2.74% from a day low at $234.31 to a day high of $240.74. The price has risen in 6 of the last 10 days and is up by 1.28% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 85 thousand more shares were traded than the day before. In total, 442 thousand shares were bought and sold for approximately $104.64 million.
The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $232.71 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 12.38% during the next 3 months and, with a 90% probability hold a price between $261.53 and $294.54 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
UTHR Signals & Forecast
The United Therapeutics Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $235.25 and $236.40. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -5.04%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for United Therapeutics Corporation stock
United Therapeutics Corporation finds support from accumulated volume at $235.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $6.43 (2.74%) between high and low. For the last week, the stock has had daily average volatility of 2.31%.
Our recommended stop-loss: $226.40 (-4.45%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 27 days ago.)
Trading Expectations (UTHR) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect United Therapeutics Corporation to open at $237.33, and during the day (based on 14 day Average True Range), to move between $230.64 and $243.22, which gives a possible trading interval of +/-$6.29 (+/-2.66%) up or down from last closing price. If United Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 5.31% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $236.97 (0.02%) than the support at $235.78 (0.49%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is United Therapeutics Corporation stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for United Therapeutics Corporation stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 2.141 Buy Candidate Upgraded
Predicted Opening Price for United Therapeutics Corporation of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $237.33 ( 0.167%) | $236.93 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for UTHR
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 243.76 | 2.88 % | |
| R2 | 241.30 | 1.84 % | ||
| R1 | 239.78 | 1.20 % | ||
| Current price: | 236.93 | |||
| Support | S1 | 234.87 | -0.87 % | |
| S2 | 233.35 | -1.51 % | ||
| S3 | 230.90 | -2.55 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 244.26 | 3.09 % | |
| R2 | 243.27 | 2.68 % | ||
| R1 | 236.97 | 0.0169 % | ||
| Current price | 236.93 | |||
| Support | S1 | 235.78 | -0.485% | |
| S2 | 229.72 | -3.04% | ||
| S3 | 228.26 | -3.66% |
FAQ
Click here for our free guide on how to buy United Therapeutics Corporation Stock.
